| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0005700 | Exon-Exon | chr16:68155890-68260462 | chr16:68121987-68226559 | 210 nt | 0.5286 |
| hsa_NFATC3_0005800 | Exon-Exon | chr16:68155935-68160513 | chr16:68122032-68126610 | 163 nt | 0.4479 |
| hsa_chr16_0275100 | Intergenic-Intergenic | chr16:68155941-68191844 | chr16:68122038-68157941 | 1320 nt | 0.4659 |
| hsa_chr16_0275200 | Intergenic-Intergenic | chr16:68155974-68156269 | chr16:68122071-68122366 | 296 nt | 0.4155 |
| hsa_NFATC3_0006200 | Exon-Exon | chr16:68156154-68160513 | chr16:68122251-68126610 | 1034 nt | 0.4836 |
| hsa_NFATC3_0006300 | Exon-Exon | chr16:68156154-68217269 | chr16:68122251-68183366 | 1731 nt | 0.4558 |
| hsa_NFATC3_0006000 | Exon-Exon | chr16:68156154-68225678 | chr16:68122251-68191775 | 2739 nt | 0.4578 |
| hsa_NFATC3_0006100 | Exon-Exon | chr16:68156154-68248335 | chr16:68122251-68214432 | 2843 nt | 0.4583 |
| hsa_NFATC3_0006400 | Exon-Exon | chr16:68156370-68157024 | chr16:68122467-68123121 | 655 nt | 0.5084 |
| hsa_NFATC3_0006500 | Exon-Exon | chr16:68156628-68160463 | chr16:68122725-68126560 | 510 nt | 0.4608 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].